Research report: Adjuvant EGFR-TKI therapy in completely resected non–small cell lung cancer with major uncommon EGFR mutations: a real-world study
A retrospective study of 154 patients links adjuvant EGFR inhibitors with longer three-year disease-free survival after surgery for non-small cell ...
